Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05765227 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens
A NA study of Refractive Ametropia, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT05765227: Completed NA study of Refractive Ametropia, sponsored by Alcon Research.
NCT05765227 is a NA study of Refractive Ametropia that has completed, run by Alcon Research. The registered enrollment target is 18 participants, below the 231-participant average among 5 other Refractive Ametropia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05765227, a NA study of Refractive Ametropia, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial was to evaluate the clinical performance of a manufacturing process on a frequent replacement multifocal contact lens.
Primary Outcome
VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was prespecified for this endpoint.
Conditions Studied
Interventions
- DEVICE Lehfilcon A multifocal contact lenses
- DEVICE Lotrafilcon B multifocal contact lenses
- DEVICE Hydrogen peroxide-based cleaning and disinfection system
Study Locations (1)
Georgia
- Johns Creek Research Clinic - Johns Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-03-08 |
| Est. Completion | 2023-03-30 |
| Phase | NA |
What the finished NCT05765227 record still lists
NCT05765227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 231-participant average among 5 other Refractive Ametropia trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Refractive Ametropia appearing as the primary indexed condition, and to 3 interventions - of which Lehfilcon A multifocal contact lenses is the first listed.
NCT05765227 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05765227 about?
NCT05765227 is a clinical study titled "Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens". The purpose of this clinical trial was to evaluate the clinical performance of a manufacturing process on a frequent replacement multifocal contact lens.
What is the current status of trial NCT05765227?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2023-03-08. Estimated completion is 2023-03-30.
What conditions does trial NCT05765227 study?
This clinical trial studies the following conditions: Refractive Ametropia.
What interventions are being tested in trial NCT05765227?
The interventions under investigation include: Lehfilcon A multifocal contact lenses (DEVICE), Lotrafilcon B multifocal contact lenses (DEVICE), Hydrogen peroxide-based cleaning and disinfection system (DEVICE).
Who is sponsoring clinical trial NCT05765227?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05765227 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Ametropia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Two Daily Disposable Lenses
COMPLETED · NA
-
Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens
COMPLETED · NA
-
Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens
COMPLETED · NA
-
The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses
COMPLETED · NA
-
Air Optix Night and Day Aqua (AONDA) Retrospective Study 1
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI